As reviewed in this paper, meningococcal disease epidemiology varies substantially by
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …

The meningococcal serogroup C conjugate (MCC) vaccine programme in England has
successfully controlled the incidence of serogroup C disease, as a result of high short-term …

Background Neisseria meningitidis is an important cause of meningitis and septicaemia, but
most infected individuals experience a period of asymptomatic carriage rather than disease. …

Methods and results Since December 1999 we have investigated the vaccination history of
all cases of serogroup C disease confirmed by the meningococcal reference unit of the …

Pneumonia is an important cause of illness and death in England. To describe trends in
pneumonia hospitalizations, we extracted information on all episodes of pneumonia that …

Effective vaccines provide direct protection to immunized individuals, but may also provide
benefits to unvaccinated individuals by reducing transmission and thereby lowering the risk of …

Background In preparation for the introduction of MenAfriVac, a meningococcal group A
conjugate vaccine developed for the African meningitis belt, an enhanced meningitis …

The laboratory confirmation of meningococcal disease and characterization of Neisseria
meningitidis isolates was improved considerably in England and Wales by the Meningococcal …

In the African meningitis belt, epidemics of meningococcal disease occur periodically, although
unpredictably, every few years. These epidemics continue to cause havoc but new efforts …

Background The past two decades have seen expansion of childhood vaccination programmes
in low-income and middle-income countries (LMICs). We quantify the health impact of …